WO2008129532A3 - Device system and method for monitoring and controlling blood analyte levels - Google Patents

Device system and method for monitoring and controlling blood analyte levels Download PDF

Info

Publication number
WO2008129532A3
WO2008129532A3 PCT/IL2008/000488 IL2008000488W WO2008129532A3 WO 2008129532 A3 WO2008129532 A3 WO 2008129532A3 IL 2008000488 W IL2008000488 W IL 2008000488W WO 2008129532 A3 WO2008129532 A3 WO 2008129532A3
Authority
WO
WIPO (PCT)
Prior art keywords
monitoring
device system
controlling blood
analyte levels
blood analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2008/000488
Other languages
French (fr)
Other versions
WO2008129532A2 (en
Inventor
Morris Laster
Moshe Phillip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C G M 3 Ltd
Original Assignee
C G M 3 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to MX2009011246A priority Critical patent/MX2009011246A/en
Priority to AU2008242142A priority patent/AU2008242142A1/en
Priority to EP08738190A priority patent/EP2139393A2/en
Priority to US12/450,919 priority patent/US20100145317A1/en
Priority to JP2010503664A priority patent/JP2010524554A/en
Priority to CA002684457A priority patent/CA2684457A1/en
Priority to CN200880021305A priority patent/CN101715317A/en
Application filed by C G M 3 Ltd filed Critical C G M 3 Ltd
Publication of WO2008129532A2 publication Critical patent/WO2008129532A2/en
Priority to IL201528A priority patent/IL201528A0/en
Anticipated expiration legal-status Critical
Publication of WO2008129532A3 publication Critical patent/WO2008129532A3/en
Priority to US13/673,198 priority patent/US20130144144A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6864—Burr holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031—Implanted circuitry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4504—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A device and system for monitoring an analyte in a subject and for controlling blood analyte levels are provided. The device and system include a sensor element which is designed and configured for detecting the analyte in blood flowing through the bone of the subject.
PCT/IL2008/000488 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels Ceased WO2008129532A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2008242142A AU2008242142A1 (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels
EP08738190A EP2139393A2 (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels
US12/450,919 US20100145317A1 (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels
JP2010503664A JP2010524554A (en) 2007-04-19 2008-04-09 Apparatus system and method for monitoring and controlling blood analyte levels
CA002684457A CA2684457A1 (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels
MX2009011246A MX2009011246A (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels.
CN200880021305A CN101715317A (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels
IL201528A IL201528A0 (en) 2007-04-19 2009-10-15 Device system and method for monitoring and controlling blood analyte levels
US13/673,198 US20130144144A1 (en) 2007-04-19 2012-11-09 Device system and method for monitoring and controlling blood analyte levels

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90784507P 2007-04-19 2007-04-19
US60/907,845 2007-04-19
US99667607P 2007-11-29 2007-11-29
US60/996,676 2007-11-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/673,198 Continuation-In-Part US20130144144A1 (en) 2007-04-19 2012-11-09 Device system and method for monitoring and controlling blood analyte levels

Publications (2)

Publication Number Publication Date
WO2008129532A2 WO2008129532A2 (en) 2008-10-30
WO2008129532A3 true WO2008129532A3 (en) 2010-02-25

Family

ID=39876053

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2008/000488 Ceased WO2008129532A2 (en) 2007-04-19 2008-04-09 Device system and method for monitoring and controlling blood analyte levels

Country Status (8)

Country Link
US (1) US20100145317A1 (en)
EP (1) EP2139393A2 (en)
JP (1) JP2010524554A (en)
CN (1) CN101715317A (en)
AU (1) AU2008242142A1 (en)
CA (1) CA2684457A1 (en)
MX (1) MX2009011246A (en)
WO (1) WO2008129532A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105455782A (en) * 2015-12-17 2016-04-06 李婷 Non-invasive spine marrow lesion detector

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
KR101397386B1 (en) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US8080003B1 (en) * 2006-02-02 2011-12-20 Paunceforte Technologies, LLC Method and implantable apparatus for the intra-osseal monitoring of biological substances in the bone marrow
US20100202966A1 (en) * 2006-03-28 2010-08-12 Yossi Gross Implantable Sensor
US20100160749A1 (en) * 2008-12-24 2010-06-24 Glusense Ltd. Implantable optical glucose sensing
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
JP5795584B2 (en) 2009-08-31 2015-10-14 アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． Medical device
US20110082356A1 (en) * 2009-10-01 2011-04-07 Medtronic Minimed, Inc. Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
ES2861359T3 (en) 2009-12-01 2021-10-06 Exthera Medical Corp Device to remove cytokines from the blood with surface immobilized polysaccharides
ES2881798T3 (en) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Medical device inserters and medical device insertion and use procedures
WO2012077102A1 (en) * 2010-12-06 2012-06-14 Cgm3 Ltd. Implant cage
WO2012112724A1 (en) * 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9037205B2 (en) 2011-06-30 2015-05-19 Glusense, Ltd Implantable optical glucose sensing
JP6321540B2 (en) 2011-07-26 2018-05-09 グリセンス インコーポレイテッド Implantable analyte sensor with hermetically sealed housing and method of manufacturing the sensor
EP2766887B1 (en) 2011-10-11 2019-12-18 Senseonics, Incorporated Electrodynamic field strength triggering system
AU2012352560B2 (en) 2011-12-11 2017-01-19 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
US10660550B2 (en) 2015-12-29 2020-05-26 Glysens Incorporated Implantable sensor apparatus and methods
US10561353B2 (en) 2016-06-01 2020-02-18 Glysens Incorporated Biocompatible implantable sensor apparatus and methods
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9703751B2 (en) * 2012-11-07 2017-07-11 Nokia Technologies Oy Apparatus and sensors for attachment to the apparatus
WO2014110327A1 (en) * 2013-01-10 2014-07-17 Emory University Systems, methods and computer readable storage media for analyzing a sample
WO2014159229A1 (en) * 2013-03-14 2014-10-02 Becton, Dickinson And Company Continuous glucose monitoring on-body sensor having a visual display
EP4736749A2 (en) 2013-04-30 2026-05-06 Abbott Diabetes Care Inc. Systems, devices, and methods for energy efficient electrical device activation
BR112015032134B1 (en) 2013-06-24 2022-05-10 Exthera Medical Corporation Method of end-linking a non-reducing mannose to a substrate and bead having an end-linked mannose
BR112016009827B1 (en) 2013-11-08 2021-10-26 Exthera Medical Corporation IN VITRO METHOD TO CONCENTRATE INFECTIOUS PATHOGENS PRESENT IN A BIOLOGICAL SAMPLE OBTAINED FROM AN INDIVIDUAL SUSPECTED OF BEING INFECTED WITH SUCH PATHOGENS, CONCENTRATOR AND KIT
WO2015102522A1 (en) * 2013-12-30 2015-07-09 Swemac Innovation Ab Instrument for use in measuring blood flow in the femoral head
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
KR101443827B1 (en) * 2014-02-18 2014-09-26 현기봉 Apparatus for noninvasive blood constituent measurement
EP3134146B1 (en) 2014-04-24 2024-12-25 ExThera Medical Corporation Method for removing bacteria from blood using high flow rate
US10857283B2 (en) 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
EP3206567A1 (en) 2014-10-13 2017-08-23 Glusense, Ltd. Analyte-sensing device
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
CA2984939A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
EP3445872A1 (en) 2016-04-20 2019-02-27 Glusense Ltd. Fret-based glucose-detection molecules
US10638962B2 (en) 2016-06-29 2020-05-05 Glysens Incorporated Bio-adaptable implantable sensor apparatus and methods
EP3275362B1 (en) * 2016-07-28 2022-12-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for monitoring a condition of a living being
JP6818294B2 (en) * 2016-09-05 2021-01-20 学校法人 埼玉医科大学 Evaluation method of therapeutic effect of drug in cancer patients, creation method of evaluation data of therapeutic effect, evaluation device of therapeutic effect and evaluation program of therapeutic effect
CN107788993A (en) * 2016-09-06 2018-03-13 陈治宇 Anaesthetic concentration on-line real time monitoring system in a kind of blood
US20180153450A1 (en) 2016-12-02 2018-06-07 Glysens Incorporated Analyte sensor receiver apparatus and methods
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11766550B2 (en) * 2017-05-21 2023-09-26 Veris Health, Inc. Implantable medication infusion port with physiologic monitoring
JP6857903B2 (en) * 2017-07-19 2021-04-14 大信貿易株式会社 Device for acquiring body fluid information
US11278668B2 (en) 2017-12-22 2022-03-22 Glysens Incorporated Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods
US11255839B2 (en) 2018-01-04 2022-02-22 Glysens Incorporated Apparatus and methods for analyte sensor mismatch correction
WO2019177938A1 (en) * 2018-03-12 2019-09-19 Admetsys Corporation Intraosseous implantable biological sensor
WO2019236850A1 (en) 2018-06-07 2019-12-12 Abbott Diabetes Care Inc. Focused sterilization and sterilized sub-assemblies for analyte monitoring systems
EP4070730A1 (en) 2018-06-07 2022-10-12 Abbott Diabetes Care, Inc. Focused sterilization and sterilized sub-assemblies for analyte monitoring systems
MX2021007294A (en) 2018-12-21 2021-07-15 Abbott Diabetes Care Inc Systems, devices, and methods for analyte sensor insertion.
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
CN111110249B (en) * 2019-12-27 2021-08-27 中国科学院深圳先进技术研究院 Blood glucose fluctuation evaluation method and evaluation device
EP4203819B1 (en) 2020-08-31 2024-07-31 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion
US12576599B2 (en) 2020-09-15 2026-03-17 Abbott Diabetes Care Inc. Systems, devices, and methods for an analyte sensor
ES3000715T3 (en) 2020-09-15 2025-03-03 Abbott Diabetes Care Inc Device for analyte monitoring
US12186076B2 (en) 2021-02-09 2025-01-07 Medtronic, Inc. Optical based glucose sensor
JP2024527596A (en) 2021-07-16 2024-07-25 アボット ダイアベティス ケア インコーポレイテッド Systems, devices, and methods for analyte monitoring

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5551953A (en) * 1994-10-31 1996-09-03 Alza Corporation Electrotransport system with remote telemetry link
US5960797A (en) * 1991-04-29 1999-10-05 Board Of Regents, The University Of Texas System Implantable intraosseous device for rapid vascular access
WO2000013003A1 (en) * 1998-08-26 2000-03-09 Sensors For Medicine And Science, Inc. Optical-based sensing devices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080003B1 (en) * 2006-02-02 2011-12-20 Paunceforte Technologies, LLC Method and implantable apparatus for the intra-osseal monitoring of biological substances in the bone marrow

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5960797A (en) * 1991-04-29 1999-10-05 Board Of Regents, The University Of Texas System Implantable intraosseous device for rapid vascular access
US5551953A (en) * 1994-10-31 1996-09-03 Alza Corporation Electrotransport system with remote telemetry link
WO2000013003A1 (en) * 1998-08-26 2000-03-09 Sensors For Medicine And Science, Inc. Optical-based sensing devices

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105455782A (en) * 2015-12-17 2016-04-06 李婷 Non-invasive spine marrow lesion detector

Also Published As

Publication number Publication date
US20100145317A1 (en) 2010-06-10
AU2008242142A1 (en) 2008-10-30
CA2684457A1 (en) 2008-10-30
CN101715317A (en) 2010-05-26
JP2010524554A (en) 2010-07-22
EP2139393A2 (en) 2010-01-06
WO2008129532A2 (en) 2008-10-30
MX2009011246A (en) 2010-01-29

Similar Documents

Publication Publication Date Title
WO2008129532A3 (en) Device system and method for monitoring and controlling blood analyte levels
WO2008039944A3 (en) Method and apparatus for providing analyte sensor insertion
EP1830088A4 (en) Method and device for detecting abnormality of vehicle and sensor unit of the device
BRPI0907379A2 (en) Method for controlling an alarm in an instrument or medical system, and an instrument or medical system for detecting a physiological parameter and for controlling an alarm
WO2009063443A3 (en) Medical system, apparatus and method
PL2207582T3 (en) System and method for monitoring and regulating blood glucose levels
PL2130007T3 (en) Method for monitoring and/or determining the condition of a force measurement device, and force measurement device
BRPI0814320A2 (en) METHOD FOR AUTOMATICALLY DETERMINING THE STATE OF USE OF AN ELECTRONIC MEDICAL DEVICE AND / OR ENABLING THIS ELECTRONIC MEDICAL DEVICE, AND, ELECTRONIC STETHOSCOPE.
IL178789A0 (en) Autonomous monitoring method and system, using sensors of different sensitivities
WO2012006208A3 (en) Method and/or system for determining blood glucose reference sample times
WO2009107135A3 (en) Device, system and method for modular analyte monitoring
ZA200906959B (en) Transdermal analyte monitoring systems and methods for analyte detection
PL2040776T3 (en) Method and device for monitoring an extracorporeal blood circuit
EP1980203B8 (en) Blood sensor and blood test apparatus having the same
TWI369127B (en) Motion detecting device, motion detecting method, imaging device, and monitoring system
WO2008114224A3 (en) Method and device for substance measurement
BRPI0909791A2 (en) Cartridge, sensing device and method for detecting target components in a liquid sample, and use of the sensing cartridge or device.
WO2008051576A3 (en) Optical inclusion sensor
WO2008005780A3 (en) Integrated analyte sensor and infusion device and methods therefor
SG118416A1 (en) Devices systems and methods for extracting bodily fluid and monitoring an analyte therein
EP2308435A4 (en) Disposable idaper state detecting device and disposable idaper state monitoring system
EP2191768A4 (en) Position sensor, medical device guiding system, position sensing method, and medical device guiding method
HUE058823T2 (en) System and method for operating an electrochemical analyte detector
WO2007137285A3 (en) Fluid access interface
WO2008058084A3 (en) Analyte sensore method and apparatus

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880021305.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08738190

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 201528

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2010503664

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2684457

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/011246

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008242142

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2008738190

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 3938/KOLNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12450919

Country of ref document: US